Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$883M |
| 2 |
Microsoft
MSFT
|
+$870M |
| 3 |
Amazon
AMZN
|
+$600M |
| 4 |
Meta Platforms (Facebook)
META
|
+$343M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.4M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$32.8M |
| 3 |
LPT
Liberty Property Trust
LPT
|
+$29.6M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$12.9M |
| 5 |
INXN
Interxion Holding N.V.
INXN
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.52% |
| 2 | Healthcare | 15.94% |
| 3 | Consumer Discretionary | 11.41% |
| 4 | Communication Services | 10.51% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Trupanion
TRUP
$1.33B
| $1.5M | ﹤0.01% |
57,610
+1,100
| +2% | +$34.4K |
|
1627
Coeur Mining
CDE
$18.9B
| $1.5M | ﹤0.01% |
466,500
+41,300
| +10% | +$215K |
|
1628
CTS Corp
CTS
$1.8B
| $1.5M | ﹤0.01% |
60,100
+700
| +1% | +$19.1K |
|
|
ALEX
1629
DELISTED
Alexander & Baldwin
ALEX
| $1.49M | ﹤0.01% |
133,120
+1,700
| +1% | +$31.9K |
|
1630
Unisys
UIS
$206M
| $1.49M | ﹤0.01% |
121,000
+1,600
| +1% | +$20.5K |
|
|
LTHM
1631
DELISTED
Livent Corporation
LTHM
| $1.49M | ﹤0.01% |
283,135
+3,700
| +1% | +$31.1K |
|
1632
Enanta Pharmaceuticals
ENTA
$399M
| $1.48M | ﹤0.01% |
28,700
+400
| +1% | +$21.3K |
|
1633
Perdoceo Education
PRDO
$2B
| $1.47M | ﹤0.01% |
136,500
+2,200
| +2% | +$34.2K |
|
1634
Usana Health Sciences
USNA
$254M
| $1.47M | ﹤0.01% |
25,500
| – | – |
|
|
RAVN
1635
DELISTED
Raven Industries Inc
RAVN
| $1.47M | ﹤0.01% |
69,400
+700
| +1% | +$20.5K |
|
1636
Matthews International
MATW
$725M
| $1.47M | ﹤0.01% |
60,796
+500
| +0.8% | +$15.9K |
|
1637
Scholastic
SCHL
$783M
| $1.47M | ﹤0.01% |
57,700
+900
| +2% | +$29.2K |
|
|
SAFE
1638
DELISTED
Safehold Inc.
SAFE
| $1.47M | ﹤0.01% |
23,200
+3,900
| +20% | +$197K |
|
|
ENDP
1639
DELISTED
Endo International plc
ENDP
| $1.46M | ﹤0.01% |
395,800
+5,700
| +1% | +$28.9K |
|
1640
Astec Industries
ASTE
$985M
| $1.45M | ﹤0.01% |
41,500
+600
| +1% | +$23.5K |
|
1641
Jack in the Box
JACK
$362M
| $1.45M | ﹤0.01% |
41,300
-3,200
| -7% | -$218K |
|
1642
John B. Sanfilippo & Son
JBSS
$1.01B
| $1.45M | ﹤0.01% |
16,176
+200
| +1% | +$16.1K |
|
1643
Cerus
CERS
$574M
| $1.43M | ﹤0.01% |
308,300
+39,700
| +15% | +$180K |
|
|
SGMO
1644
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.43M | ﹤0.01% |
224,860
+3,400
| +2% | +$25.2K |
|
1645
Verra Mobility
VRRM
$717M
| $1.43M | ﹤0.01% |
200,600
+3,200
| +2% | +$42.6K |
|
1646
AZZ Inc
AZZ
$4.54B
| $1.43M | ﹤0.01% |
50,700
+600
| +1% | +$23K |
|
|
NAV
1647
DELISTED
Navistar International
NAV
| $1.43M | ﹤0.01% |
86,500
+1,100
| +1% | +$32.1K |
|
|
CHCT
1648
Community Healthcare Trust
CHCT
$436M
| $1.42M | ﹤0.01% |
37,200
+2,000
| +6% | +$87K |
|
1649
Stride
LRN
$3.42B
| $1.42M | ﹤0.01% |
75,500
+2,400
| +3% | +$44.3K |
|
|
GLUU
1650
DELISTED
Glu Mobile Inc.
GLUU
| $1.42M | ﹤0.01% |
226,200
+2,800
| +1% | +$18K |
|
Similar funds
Swiss National Bank's Q1 2020 Portfolio in Review
As of Q1 2020, Swiss National Bank held 2,510 positions worth $94.2B, down 3.4% from $97.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Swiss National Bank deployed $18.4B of net new capital in Q1 2020, opening 4 new positions and adding to 1,998 existing holdings. Its largest new stake was Luckin Coffee Inc. American Depositary Shares: 165,417 shares worth $4.5M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was C.H. Robinson, an estimated $5.64M trimmed.
- Swiss National Bank's largest Q1 2020 buy was Luckin Coffee Inc. American Depositary Shares: 165,417 shares worth $4.5M.
- Swiss National Bank added most to Apple in Q1 2020, an estimated $883M increase.
- Swiss National Bank's biggest Q1 2020 reduction was C.H. Robinson, cutting an estimated $5.64M.
- Swiss National Bank fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $52.4M.
- Swiss National Bank's ten largest holdings make up 22% of its $94.2B portfolio in Q1 2020.
- Swiss National Bank opened 4 new positions and closed 30 in Q1 2020.
- Swiss National Bank's portfolio value fell 3.4% quarter-over-quarter to $94.2B.
Based on Swiss National Bank's 13F filing for Q1 2020, filed 8 May 2020.